Gyre Therapeutics Inc (GYRE)

Operating Expenses

$129.25M

TTM · Period ending: · USD

GYRE logo

GYRE Operating Expenses

Latest reported$129.25M
GYRE Operating Expenses ($10.45M → $129.25M)
High-resolution chart · PNG

GYRE operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
99,681,000
85,710,000
176,044,000
88,294,000
83,394,000
69,155,000
57,131,000
33,828,000
22,667,000
20,817,000
15,552,000
8,642,000
50,845,000
62,280,000
104,902,000
70,601,000
64,696,000
47,480,000
42,632,088
27,484,000
30,639,900
27,933,355
21,779,000
23,045,000
10,454,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.